针对艾滋病毒/艾滋病的益生菌研究当前趋势和未来方向
Xinxin Cui1, Zhanpeng Xie1, Zhen Wu1
1Medical School of Shihezi University, Xinjiang, China.
Frontiers in microbiology
|January 13, 2025
概括
本综述分析了益生菌和艾滋病毒/艾滋病的研究,发现2017年达到峰值. 未来的研究应该探索益生菌菌株,代谢物及其在艾滋病毒/艾滋病疫苗中的作用.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 益生菌和艾滋病毒/艾滋病的研究正在增长.
- 了解肠道微生物群和艾滋病毒之间的相互作用对于治疗干预至关重要.
研究的目的:
- 系统地审查有关益生菌和艾滋病毒/艾滋病的当前研究.
- 确定该领域的未来研究热点和趋势.
- 分析科学成果和合作模式.
主要方法:
- 从科学网络核心集合数据库中对文献进行图书法分析.
- 使用CiteSpace,VOSviewers和Bibliometrix进行数据分析.
- 包括到2024年5月13日发表的文章.
主要成果:
- 总共有90件物品被确定.
- 出版量在2017年达到峰值,随后出现下降.
- 美国在出版方面处于领先地位,其中G·里德博士是最多产的作者.
- 关键词包括免疫激活,炎症和微生物转移.
- 疫苗成为潜在的未来研究重点.
结论:
- 未来的研究应该优化益生菌类型,时间和对艾滋病毒/艾滋病的菌株.
- 建议在疫苗开发中研究诸如短链脂肪酸等益生菌代谢物.
- 需要进一步的研究来阐明益生菌在艾滋病毒/艾滋病中的确切作用机制.
相关概念视频
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...


